Winston Pharmaceuticals, Inc. (WPHM)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.2940 - Volume
375 - Avg. Volume
375 - Market Cap (intraday)
77 - Beta (5Y Monthly) -940.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0350 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.
www.winstonlabs.com9
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: WPHM
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WPHM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WPHM
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-170.44%
Return on Assets (ttm)
-58.62%
Return on Equity (ttm)
-204.60%
Revenue (ttm)
1.37M
Net Income Avi to Common (ttm)
-2.34M
Diluted EPS (ttm)
-0.0350
Balance Sheet and Cash Flow
Total Cash (mrq)
677.52k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.71M
Company Insights: WPHM
WPHM does not have Company Insights